Abstract
Neisseria gonorrhoeae is a common bacterial sexually transmitted infection. Like all Gram-negative bacteria, the outer membrane of the gonococcus is rich in endotoxin, a known ligand for Toll-like receptor (TLR)4. However, the role of endotoxin and that of its cognate receptor TLR4 in the mucosal response to acute gonococcal infection in the genital tract of women is unclear. To test this, we examined the course of infection after vaginal inoculation of N. gonorrhoeae in mice carrying the Lpsd mutation in Tlr4, which renders them unresponsive to endotoxin. Although there was no difference in the duration of colonization, Lpsd mice had a significantly higher peak bacterial burden which coincided with a massive polymorphonuclear cell influx and concomitant upregulation of a subset of inflammatory cytokine and chemokine markers. Notably, infected Lpsd mice showed a decrease in interleukin-17, suggesting that Th17 responses are more dependent on TLR4 signaling in vivo. Defective polymorphonuclear cell-mediated and complement-independent serum killing of gonococci in Lpsd mice was also observed and may account for the increased bacterial burden. This is the first in vivo evidence that TLR4-regulated factors modulate early inflammatory responses to gonococcal infection in the female reproductive tract and control bacterial replication.
Similar content being viewed by others
Introduction
Neisseria gonorrhoeae is the second most commonly reported notifiable disease in the United States, and infections due to gonorrhea are associated with development of pelvic inflammatory disease in women, which can lead to tubal infertility and chronic pelvic pain.1 In addition, gonococcal infections have been reported to enhance human immunodeficiency virus transmission in co-infected individuals.2 Recently released statistics from the CDC1 (Centers for Disease Control) for 2009 show that a record-low 301,174 cases of gonorrhea were reported in the United States that year, reflecting ∼111 cases per 100,000 people. However, although overall rates were decreased from previous years, significant disparities remain with regard to gender and race. In this report, the CDC noted that 71% of all cases of gonorrhea occurred in African Americans, and African-American women aged 15 through 19 years showed the highest rates of 2,613.8 cases per 100,000 people.
Gonorrhea is almost exclusively transmitted by close sexual contact, and can occur at several mucosal surfaces, including the urethra, cervix, rectum, and pharynx. Early events in the establishment of infection involve interactions between gonococci and epithelial cells, which lead to colonization of the mucosal surface, release of local inflammatory mediators, and recruitment of professional immune cells. The current model for gonococcal pathogenesis in women suggests that N. gonorrhoeae is unable to invade the squamous epithelium of the vagina and ectocervix, but rather colonizes and transmigrates across the columnar epithelium of the uterine endocervix.3 In women, infection with gonorrhea usually remains localized to the lower reproductive tract, where it can induce an inflammatory cervical exudate containing polymorphonuclear cells (PMNs) with intracellular gonococci. However, like many sexually transmitted infections in women, gonococcal cervicitis is often described as subclinical or asymptomatic as patients rarely report subjective evidence of increased vaginal discharge or pelvic pain. This can lead to continued transmission between sexual partners and delayed treatment.4 The latter is believed to contribute to the development of pelvic inflammatory disease in a subset of women. Pelvic inflammatory disease is a syndrome associated with an acute infection of the upper genital tract structures, including the uterus, oviducts, and ovaries, which can then lead to complications of tubal infertility and ectopic pregnancy.5, 6
Although in vitro studies have implicated the involvement of several innate immune receptors and pathways in the induction of inflammatory signals during gonococcal infection, none have been able to adequately address the complex interaction of various cell types at the mucosal surface during an in vivo infection in women. To better address this aspect of gonococcal pathogenesis, we developed a female mouse genital tract infection model that mimics several aspects of human infection.7 The model, although limited by a number of host restrictions, has been used successfully to study several aspects of host–pathogen interactions during gonococcal infections. In this study, we used our model to evaluate the role of endotoxin (lipopolysaccharide, LPS), a key virulence factor for all Gram-negative bacteria, in the pathogenesis of lower genital tract infection with N. gonorrhoeae. Endotoxin is a potent proinflammatory trigger by virtue of its ability to engage the Toll-like receptor (TLR)4 receptor complex, which is expressed on the surface of various cells including monocytes, macrophages, dendritic cells, and PMNs (reviewed in the study by Palsson-McDermott and O’Neill8). We examined the course of infection and production of proinflammatory cytokines in mice that are sufficient or deficient in TLR4 signaling by comparing BALB/c mice and BALB/c mice carrying the Lpsd mutation in Tlr4.9 Although there was no difference in the rate of clearance of infection between wild-type and Lpsd-mutant mice, the colonization load and a number of acute inflammatory markers were significantly lower in wild-type mice. TLR4-mutant mice displayed an intense inflammatory cytokine and chemokine response in vivo, with a massive PMN influx and a significantly higher peak bacterial burden. The only cytokines that appeared to be downregulated in vivo were interleukin (IL)-17 and related family members, including IL-6, IL-21, and IL-22, suggesting that Th17-mediated responses were dependent on TLR4 signaling events. Interestingly, induction of proinflammatory cytokines in vitro was largely dependent on TLR4 function, suggesting that a more complex interplay of cell types and endogenous flora occurs in vivo. Finally, PMN-mediated and complement-independent serum killing of gonococci was defective in the absence of TLR4 signaling, indicating a role for TLR4 in mediating antibacterial responses. These data suggest that a TLR4-regulated factor provides a barrier to gonococcal colonization, and that TLR4 has a negative role in regulating inflammation during gonococcal cervicitis.
Results
TLR4-mutant mice have a higher colonization load of N. gonorrhoeae after vaginal inoculation
Female BALB/c mice exhibit a significant localized PMN influx in response to gonococcal infection in the lower reproductive tract, and support high levels of colonization over the course of infection.10, 11 To determine the importance of TLR4 signaling during experimental murine infection, we took advantage of the C.C3-tlr4LPS-d/J mouse strain, in which C3H/HeJ mice were back bred onto the BALB/c background to create a congenic BALB/c mouse strain that contains a segment of chromosome 4, which includes the Lpsd allele of Tlr4.9 Thus, these mice, which we will refer to as BALB/c-Lpsd, express the Lpsd mutation in Tlr412 and, like the C3H/HeJ parental strain, are unresponsive to LPS. We found no difference in the duration of gonococcal colonization in BALB/c mice (mean, 7.1 days; range 0–16) vs. BALB/c-Lpsd mice (mean, 9.3 days; range 2–16). However, as shown in Figure 1a, a significant difference in the bacterial burden was observed between days 1 and 10 of infection, with ∼1 to 2 logs more bacteria recovered from BALB/c-Lpsd mice than from BALB/c mice. This result suggests that TLR4 is required for control of bacterial replication during infection in the lower reproductive tract of female mice.
We recently reported that, in contrast to BALB/c mice, mice of the C3H/HeN strain are resistant to gonococcal colonization.10 Therefore, we were curious whether loss of TLR4-mediated signaling would have any effect on this strain that, otherwise, seemed unable to support gonococcal infection. To test this possibility, we compared the colonization loads of C3H/HeN mice, which are wild type for TLR4, with C3H/HeJ mice, which express the Lpsd mutation in Tlr4.12 A group of BALB/c mice was inoculated in parallel. As expected, C3H/HeN mice were resistant to infection with N. gonorrhoeae (mean duration of recovery, 0.7 day; range 0–2) compared with BALB/c mice (mean duration of recovery, 7.5 days; range 2–9), confirming our previously published data.10 In contrast, C3H/HeJ mice exhibited a longer duration of infection (2.3 days; range 0–5) and significantly higher colonization load than did C3H/HeN mice, although they did not reach the same level of colonization as did BALB/c mice (Figure 1b). Although the basis of resistance in the C3H/HeN mouse strain remains unknown, these data suggest that innate resistance to gonococcal colonization of this inbred mouse strain can, at least partially, be overcome by the loss of TLR4-mediated signaling events.
TLR4-mutant mice generate an exaggerated inflammatory response to gonococcal infection in vivo
BALB/c mice upregulate vaginal proinflammatory cytokines and chemokines in response to infection with N. gonorrhoeae, the expression of which peaks on day 5 and coincides with a concomitant PMN influx. We hypothesized that the inability to control early gonococcal replication might reflect inadequate proinflammatory signaling in the absence of TLR4 function, and therefore examined the vaginal milieu for evidence of inflammation by looking for PMNs in vaginal smears and measuring the levels of some classic proinflammatory cytokines and chemokines, specifically IL-1β, tumor necrosis factor (TNF)-α, keratinocyte chemoattractant (KC; CXCL1), and macrophage inflammatory protein 2 (MIP-2; CXCL2), in vaginal washes from infected and uninfected mice of each background. To our surprise, we detected significantly higher percentages of vaginal PMNs on days 4–7 of infection in BALB/c-Lpsd mice compared with wild-type BALB/c mice, with as many as 60% PMNs detected in TLR4-mutant mice that were colonized with high numbers of N. gonorrhoeae (Figure 2a and d). Higher numbers of PMNs were also detected within genital tract tissues and within the vaginal lumen from TLR4-mutant mice using a granulocyte-specific stain (Figure 2b, c, e, and f). Coincident with the PMN influx, we observed upregulation of IL-1β, TNF-α, KC, and MIP-2 in the vaginal washes of infected mice over time; however, BALB/c-Lpsd mice had significantly higher levels than did BALB/c mice (Figure 3). This difference was most pronounced for the potent neutrophil chemoattractants MIP-2 and KC, which remained elevated relative to BALB/c mice even out to 7 days. It is noteworthy that we found that at baseline, uninfected control BALB/c-Lpsd mice had higher levels of proinflammatory cytokines and chemokines than did uninfected control BALB/c mice, with levels of IL-1β and TNF-α (P ≤0.02, day 3) and KC (days 1 (P=0.01) and 3 (P=0.04)) significantly different between these two groups (data not shown). These data suggest that the TLR4 mutation might have an effect on basal secretion of proinflammatory mediators that could also affect the threshold of activation by bacterial ligands.
Cells from TLR4-mutant mice are hyporesponsive to N. gonorrhoeae when stimulated in vitro
One possible explanation for the elevated inflammatory markers in BALB/c-Lpsd-infected mice was that they were hyperresponsive to the TLR4-independent bacterial ligands encountered during infection, such as bacterial lipoproteins and porin, which activate TLR2. To determine whether BALB/c-Lpsd mice had altered expression of TLR2 relative to wild-type BALB/c mice, we looked for evidence of TLR2 on the surface of bone marrow-derived macrophages (BMDMs) by flow cytometry, and tested whether protein expression was altered in response to treatment with N. gonorrhoeae or other TLR ligands. As shown in Figure 4, we found that both strains of mice expressed similar levels of TLR2 on the surface, which were upregulated in response to exposure to TNF-α, the synthetic triacylated gonococcal lipopeptide H.8/Lip13 and to lysates of N. gonorrhoeae FA1090. Predictably, only the BALB/c strain upregulated TLR2 in response to LPS, whereas BALB/c-Lpsd did not. These data suggest that TLR2 expression in the BALB/c-Lpsd strain is not significantly altered compared with BALB/c mice.
To determine whether cells derived from BALB/c and BALB/c-Lpsd mice responded similarly to TLR ligands and N. gonorrhoeae, we next examined the response of BMDM (Figure 5a) and splenic mononuclear cells (Figure 5b) in vitro. We found that cells from both mouse strains responded similarly to a TLR2 ligand, the synthetic lipopeptide Pam2-Cys-SK4 in terms of upregulation of TNF-α and IL-6, whereas cells from BALB/c-Lpsd were only unresponsive to the TLR4 ligand, LPS. However, when exposed to live N. gonorrhoeae or crude gonococcal lysates, cytokine induction was reduced in BALB/c-Lpsd mice than in BALB/c mice, although not to baseline. These results confirm that the response to N. gonorrhoeae, at least by mononuclear cells, is primarily driven by TLR4 but that TLR4-independent cell activation can occur. This finding is similar to what we previously reported with the related pathogen Neisseria meningitidis.14 We conclude from these in vitro studies that cells derived from mice carrying the Lpsd mutation in TLR4 are not hyperresponsive to TLR2 ligands or N. gonorrhoeae in vitro.
Serum and PMNs from TLR4-mutant mice are defective in killing N. gonorrhoeae in vitro
The inability of BALB/c-Lpsd mice to control infection in the presence of a marked inflammatory response was intriguing, and we therefore compared the capacity of serum and PMNs from normal BALB/c and BALB/c-Lpsd mice to kill N. gonorrhoeae. For serum-killing assays, we used heat-inactivated (HI) sera to examine complement-independent factors. Incubation of FA1090 bacteria with HI serum from BALB/c mice at a final concentration of 20% resulted in a 1–2 log decrease in recovery after 120 and 150 min incubation, compared with the number of gonococci recovered from HI serum from BALB/c-Lpsd mice (Figure 6).
To test the relative capacity of TLR4-sufficient and TLR4-deficient PMNs to kill bacteria, gonococci were serum opsonized and incubated with PMNs from BALB/c vs. BALB/c-Lpsd mice, as described in the “Methods” section. The percentage of serum used in these assays (10%) was lower than that used in the serum-killing assays (20%) and shown to not significantly kill N. gonorrhoeae at 90 min. However, serum from normal BALB/c mice was used to opsonize gonococci for phagocytic uptake by both normal and TLR4-defective PMNs to control the potential differences in the killing activity of sera from the two mouse strains at this lower concentration. Recovery of N. gonorrhoeae after incubation with PMNs from BALB/c mice was 40% reduced relative to the HI normal mouse serum (NMS) control (Figure 7). In contrast, PMNs from BALB/c-Lpsd mice, which were tested in parallel, showed no evidence of being able to kill N. gonorrhoeae at the same time point. We conclude that both cellular and heat-stable soluble factors may contribute to the inability of BALB/c-Lpsd mice to clear infection despite the induction of an intense inflammatory response.
Th17 responses are upregulated in wild-type BALB/c mice but not in Lpsd mutants
We previously reported that IL-17 responses are induced and are protective during experimental murine gonococcal infection.15 Therefore, we examined cytokines, receptors, and transcription factors known to be critical for the induction of a Th17 response to determine whether IL-17 responses were absent or less pronounced in TLR4-mutant mice. As shown in Figure 8, transcripts for retinoic acid-related orphan receptor gamma T (RORGT), signal transducer and activator of transcription 3 (STAT3), IL-6, IL-17A, IL-17E, IL-17F, IL-17 RB, IL-21, and IL-22 were highly upregulated in infected wild-type BALB/c mice compared with BALB/c-Lpsd mice by relative real-time PCR, suggesting that Th17 responses were more dependent on TLR4 signaling in vivo. Thus, although many of the classic inflammatory markers were elevated in the TLR4-mutant mouse, those involved in the IL-17 response were higher in wild-type mice. This result is consistent with the ability of wild-type mice to better control gonococcal replication and is also suggestive that Th17 responses were more dependent on TLR4 signaling.
Discussion
The role of Neisseria endotoxin in the pathogenesis of meningococcal sepsis is generally accepted, and endotoxin levels in the blood stream correlate with clinical presentation, activation of complement, coagulopathy, and plasma TNF-α and IL-6 levels.16, 17, 18, 19, 20 In contrast, the role of endotoxin in the pathogenesis of gonococcal infection, which is most often a localized mucosal infection, is less clear. Several reports with cultured human cells that suggest that the columnar epithelium of the endocervix is deficient in expression of the endotoxin receptors TLR4 and MD2, leading us to hypothesize that epithelial cell responses to gonococci are primarily driven by TLR2, which recognizes bacterial lipoproteins and neisserial porin.21, 22 However, there is the caveat that in vivo there could be alterations in TLR4 levels as a result of hormonal influences and endogenous flora.21, 23, 24 Moreover, TLR4 signaling could have a role in the pathogenesis of gonococcal cervicitis independently of epithelial cells, as professional phagocytic cells, including neutrophils, macrophages, and dendritic cells, are present in the lumen and in the submucosal space of the lower genital tract, and they express the TLR4 receptor complex and are exquisitely sensitive to endotoxin. Thus, an in vivo model is required to test the role of LPS and TLR4 signaling during gonococcal infection to examine the cooperation between multiple cell types and the panel of receptors they express.
Our approach, using the BALB/c mouse strain expressing the Lpsd mutation in TLR4, allowed us the opportunity to test the role of gonococcal endotoxin during lower reproductive tract infection in a susceptible surrogate female host. We found a significantly higher colonization load in TLR4-mutant mice than in wild-type mice, which correlated with significantly higher PMN influx. As the in vitro data demonstrate, N. gonorrhoeae is capable of inducing TNF-α and IL-6 even in the absence of TLR4 signaling. This is likely a result of signaling through TLR2 and possibly other innate immune receptors, and may therefore explain the ability of TLR4-mutant mice to upregulate inflammatory cytokines and chemokines in the lower genital tract. However, although both mouse strains mounted an inflammatory cytokine response to gonococcal infection, infected BALB/c-Lpsd mice developed a markedly exaggerated chemokine and PMN response when compared with BALB/c control mice. One possible explanation for this observation rests with the increased bacterial burden that we observed within the same time frame. The presence of more bacteria in the genital tract may drive a more exaggerated induction of the potent neutrophil chemoattractants, MIP-2 and KC, leading to a more pronounced PMN influx. In fact, the timing of the PMN peak coincided with the increased bacterial colonization that we observed, which is consistent with excessive bacterial replication driving the induction of proinflammatory mediators through TLR4-independent pathways. It is noteworthy that although interferon-γ has been reported to suppress both MIP-2 and mouse KC secretion,25, 26 we found no detectable levels of interferon-γ in either mouse strain after inoculation with N. gonorrhoeae. Thus, the explanation for increased chemoattractants is not a result of differential interferon-γ production in the two genetic backgrounds. Additional factors may have contributed to the massive number of PMNs detected in the genital tract in TLR4-mutant mice. For example, we cannot exclude an additional role for TLR4 signaling in either the induction of PMN apoptosis or in the clearance of apoptotic PMNs by activated macrophages.
The more interesting question then becomes, why did the TLR4-mutant strain fail to control early bacterial replication, especially in light of the massive PMN influx that we observed? The role of PMNs in controlling gonococcal replication and clearance is a topic of debate in the field of gonococcal pathogenesis. The hallmark of gonorrhea is the appearance of Gram-negative diplococci within PMNs in genital secretions,27, 28, 29 but it remains controversial whether these intracellular bacteria are replicating or are in the process of being killed. One of the earliest reports to promote the idea that gonococci are rapidly killed within PMNs was by Watt,30 and numerous subsequent studies supported this model.31, 32, 33 However, Casey et al.34 later reported that although the majority of intracellular gonococci within PMNs are killed by O2-independent antimicrobial systems, a small subset of intracellular bacteria, ∼2%, are able to survive and replicate. Similar results were found by Simons et al.35 and Criss et al.,36 although the percentage of surviving bacteria differs from study to study. Our observation that PMNs from TLR4-mutant mice are less able to kill gonococci over time suggests that TLR4 activation is required for PMNs to limit bacterial replication. Moreover, our data that HI serum from TLR4-mutant mice is also defective in bacterial killing suggests that there are additional complement-independent antibacterial factors found in serum that are dependent on TLR4 expression.
Reports on the innate immune responses to other infectious processes have similarly revealed an important role for TLR4 signaling in controlling bacterial burden. For example, Montminy et al.37 demonstrated that the absence of TLR4 activation by the hypoacylated lipid A of Yersinia pestis directly contributed to mortality. When Y. pestis was engineered to produce a more biologically active hexaacylated form of lipid A, the pathogen was completely avirulent through the subcutaneous route, demonstrating that evasion of TLR4-dependent innate immune activation by the pathogen was a virulence mechanism. Similarly, TLR4-mutant mice were found to be incapable of controlling or eradicating Gram-negative respiratory infections secondary to Klebsiella pneumoniae,38 Haemophilus influenzae,39 and Pasteurella pneumotropica.40, 41 In the same manner, we would argue that early activation of TLR4-dependent responses during the mucosal challenge of mice with N. gonorrhoeae is an important protective mechanism by the host. Evidence that removal of this essential host defense mechanism partially compensates for innate resistance of the C3H/HeN mouse strain to gonococcal colonization lends further support to this model.
One additional mechanism behind the important role of TLR4 in controlling gonococcal infection in the mouse model rests with the link between TLR4 and IL-17. Our recent report in the study by Feinen et al.15 implicates a role for IL-17 and the Th17 axis in bacterial clearance during gonococcal infection in the mouse model, as the duration of colonization was almost doubled in the IL-17 receptor-deficient mouse strain compared with control mice. Furthermore, it was reported that IL-17 induction by spleen cells from TLR4-mutant C3H/HeJ mice was markedly abrogated in response to N. gonorrhoeae compared with TLR4 wild-type mice. Our current data further support a role for TLR4 in the induction of IL-17, as we again observed a reduction in IL-17 and related cytokines in the absence of TLR4 signaling. This finding is consistent with other reports that suggest that TLR4 helps to direct the induction of Th-17 cells during infections.42, 43, 44
Although our data suggest a role for TLR4 in controlling acute bacterial burden and regulating inflammatory response, the effect was most pronounced during the time period that corresponds with the host inflammatory response (days 5–7) and was not seen at later time points. In wild-type mice, a 4–5 day period of reduced recovery began on day 5, which was followed by an increase in the number of gonococci recovered. This pattern is typical of the colonization kinetics of N. gonorrhoeae strain FA1090 in this model.7 Gonococcal colonization of estradiol-treated female mice is cyclical and seems to be hormonally regulated as periods of reduced recovery are not observed in ovariectomized mice.45 As TLR4 has been shown to be hormonally regulated,46, 47 we hypothesize that the protective effects of TLR4-mediated responses may also be cyclical. It is difficult to dissect the reason for clearance of N. gonorrhoeae in the model used here as the need for exogenously delivered estradiol to promote susceptibility to long-term N. gonorrhoeae infection in mice must also be considered. When water-soluble estradiol is used, as in this study, clearance of infection occurs at an average of 10–12 days after inoculation and coincides with the resumption of the estrous cycle,11 and administration of additional doses of estradiol later in infection sustains colonization (AE Jerse, unpublished observation). The reason that estradiol is required for infection is not known, other than it synchronizes mice into a proestrus-like state on the day of bacterial challenge, which is the most susceptible stage for experimental N. gonorrhoeae infection in mice48 and maintains an estrus-like state based on the presence of predominantly epithelial cells in vaginal smears. Clearance of infection upon resumption of the reproductive cycle may have an immunological basis; however, that involves one or more innate defenses associated with the post-ovulatory stage, which, based on similar rates of clearance of infection in wild-type and Lpsd-mutant mice, we would predict to be TLR4 independent. Effects mediated by TLR2 and other innate immune receptors, and amplification of the immune response by cytokine feedback mechanisms, thus seems to make mice fully capable of ultimately eradicating the pathogen.
Another limitation of the model that should be considered when interpreting these data is the host restriction for several receptors used by N. gonorrhoeae to adhere to and invade epithelial cells. These receptors include carcinoembryonic adherence molecules, which are the major class of opacity protein receptors49 and the human CR3 molecule,50 which although having a high degree of similarity to that of mice, is likely to be host restricted in that a monoclonal antibody that blocks gonococcal invasion of human cells through this receptor did not stain genital tract tissue from infected mice (unpublished data in collaboration with Drs Jennifer Edwards and Michael Apicella). The human membrane cofactor protein (CD46) is also host restricted and hypothesized by some to serve as the neisserial pilus receptor.51 In spite of these restrictions, gonococci do adhere to murine epithelial cells through unknown ligand–receptor interactions,7 and because TLR4 is on the surface of cells, gonococcal invasion of epithelial cells through host-restricted pathways would not be required for TLR4-mediated signaling. Therefore, the significance of TLR4 signaling for infection as shown here is unlikely to be altered by the absence of these receptors.
In conclusion, this study reveals a role for TLR4 signaling in the pathogenesis of gonococcal cervicitis. The induction of proinflammatory cytokines and chemokines, as well as similar rates of clearance of the infection over the same period of time regardless of TLR4 expression, speaks to redundancy in the innate immune system whereby alternate receptors are capable of alerting the host to the danger of an invading pathogen. However, the inability of the host to control early bacterial replication during the first week of infection, and the concomitant massive PMN influx, suggests an important role for TLR4 in controlling gonococcal replication during this period, specifically through the antibacterial activity of PMNs and soluble complement-independent serum factors. It remains to be seen what impact TLR4 signaling will have in the upper reproductive tract, where its expression may be higher, and we hope to examine the role of TLR4 in additional experimental systems in future studies.
Methods
Reagents. Ultrapure LPS purified from Escherichia coli serotype O111:B4 was purchased from List Pharmaceuticals (Woburn, MA); the synthetic lipopeptides, Neisseria lipoprotein H8/Lip and Pam2-Cys-Ser-Lys4, were purchased from EMC Microcollections (Tuebingen, Germany).
Bacterial strains and culture conditions. N. gonorrhoeae FA1090 (streptomycin resistant, serum resistant) is a well-characterized serum resistant porB1B strain.52 Bacteria were cultured on GC agar with Kellogg's supplements and FeNO3 at 37°C under 7% CO2 as described previously.7 The GC agar with vancomycin, colisitin, nystatin, trimethoprim sulfate, and streptomycin was used for mouse infection experiments.7 For in vitro stimulation assays, crude whole-cell gonococcal lysates were made by subjecting bacterial suspensions to a freeze-thaw cycle at −80°C, followed by vigorous vortexing.
Experimental murine infection. Two sets of mouse strains that are congenic except for the Trl4 gene were tested: BALB/cJ (TLR4 wt) and C.C3-tlr4LPS-d/J (TLR4 mutant) from Jackson Laboratories (Bar Harbor, ME), and C3H/HeN (TLR4 wt) and C3H/HeJ (TLR4 mutant) from the National Cancer Institute. For simplicity, the C.C3-tlr4LPS-d/J mouse strain is abbreviated BALB/c-Lpsd. For all experiments, female mice were purchased at 4–6 weeks of age and allowed to acclimate to the animal facility for 10 days. Mice were then treated with water-soluble 17β-estradiol (Sigma, St Louis, MO) subcutaneously on day −2, day 0, and day 2, and antibiotics (2.4 mg streptomycin sulfate and 0.4 mg vancomycin twice daily through intraperitoneal injection and 0.04 g trimethoprim sulfate per 100 ml drinking water) were administered starting on day −2 through day 10 to promote long-term colonization with N. gonorrhoeae as described previously.11 For experiments with BALB/c and BALB/c-Lpsd mice, mice were inoculated intravaginally with 1 × 106 colony-forming units (CFU) of N. gonorrhoeae strain FA1090, which is a dose that results in infection of 80% of BALB/c mice, or phosphate-buffered saline. For experiments with BALB/c, C3H/HeN, and C3H/HeJ mice, a dose of 107CFU was used. After inoculation, the number of gonococci recovered from vaginal mucus was quantitatively cultured daily for 10 or 16 days. Vaginal smears were prepared at each time point and stained using a modified Wright stain,7 and the percentage of PMNs per 100 vaginal cells was determined by cytological differentiation under a light microscope. For immunohistochemical staining of tissue for granulocytes, whole genital tracts were harvested from three mice per group on day 7 after inoculation with N. gonorrhoeae or phosphate-buffered saline. Tissues were fixed, sectioned, and stained for immunohistochemical analysis by Histoserv Inc. (Germantown, MD) as described previously53 using anti-Gr1 (1:100) (BD Pharmagen, Franklin Lakes, NJ, catalog number 550291) and anti-rat IgG horseradish peroxidase as the primary and secondary antibodies, respectively. Sections were viewed under a light microscopy and images were scanned using Nanozoomer Digital Pathology software (Olympus, Center Valley, PA). All mouse infection experiments were performed at least twice. All protocols were approved by the Uniformed Services University of the Health Sciences and the Boston University Medical Campus Institutional Animal Care and Use Committees.
Chemokine and cytokine measurements. Vaginal washes from wild-type and TLR4-mutant mice used in the infection experiments were collected on days 1, 3, 5, and 7 by gently pipetting 50 μl of phosphate-buffered saline in and out of the vagina 20 times as described previously.54 The lavage fluid was then centrifuged at 13,000 × g for 3 min. The supernatant was frozen immediately and stored at −70°C for further analysis. Levels of IL-1β, TNF-α, KC, and MIP-2 proteins were measured using a custom Milliplex multiplex assay (Millipore, Billerica, MA). Relative real-time PCR method was used to assess gene expression levels between infected wild-type and TLR4-deficient mice as described previously.10 In brief, total RNA was extracted from pooled vaginal samples using Qiagen mini RNAeasy isolation kits (Qiagen, Valencia, CA), and 100–500 ng of total extracted RNA was then treated with genomic elimination mixture (SAbiosciences, Frederick, MD). Complementary cDNA was synthesized by adding reverse transcriptase cocktail (SAbiosciences) to DNAse-treated RNA and incubated at 42°C for exactly 15 min, after which the reaction was stopped by heating at 95°C for 5 min. Oligonucleotide primers used to measure Th17 cytokines groups were purchased from SAbiosciences. A relative change of twofold or greater between infected BALB/c vs. infected BALB/c-Lpsd mice was considered significant.
Preparation of BMDMs and splenic mononuclear cells. BMDMs from BALB/c and BALB/c-Lpsd mice were prepared as follows. In brief, the femurs and tibiae were dissected from female mice aged 6–8 weeks, bone marrows were flushed, and after lysis of red blood cells, cells were cultured in RPMI 1640 supplemented with 10% fetal bovine serum, 20 μg ml−1 gentamicin, 10 μg ml−1 ciprofloxacin, and 20% (v/v) of L929 condition medium (containing macrophage colony-stimulating factor). Cells were incubated at 37°C, 5% CO2 incubator for 7–9 days to allow macrophage differentiation, and removed from ciprofloxacin at least 3 days before infection with N. gonorrhoeae. Differentiated BMDMs were plated in 96-well plates (5 × 104 cells per well) and subsequently stimulated. Supernatants were collected after 24 h and analyzed for cytokines using commercial enzyme-linked immunosorbent assay kits for TNF-α (eBioscience, San Diego, CA) and IL-6 (R&D Systems, Minneapolis, MN). Splenic mononuclear cells were prepared as follows. The spleens were removed from mice and spleen cells were prepared. After red blood cell lysis, splenocytes were plated in 24-well plates (1 × 106 cells per well) in RPMI 1640 supplemented with 10% fetal bovine serum, 20 μg ml−1 gentamicin, and 10 μg ml−1 ciprofloxacin. Supernatants were collected 3 and 5 days after stimulation and analyzed for cytokines by enzyme-linked immunosorbent assay as described above.
Serum-killing assay. Venous blood was obtained from wild-type BALB/c and BALB/c-Lpsd mice by retro-orbital bleeding and the serum separated by centrifugation. Sera were HI at 56°C for 30 min. Strain FA1090 was suspended in phosphate-buffered saline supplemented with 0.1% gelatin, 0.01% CaCl2 and 0.01% MgCl2 and passed through 1.2-μm filters to remove bacterial aggregates and adjusted to an optical density of 0.07 at 600 nm and diluted 1:10. Overall, 20 μl (105 CFU) of the bacterial suspension was added to HI serum from BALB/c and BALB/c-Lpsd mice or buffer (no serum control) in complete Hank's balanced salt solution (with 10 mM glucose, 0.1% gelatin, 1 mM CaCl2, and 1 mM MgCl2). Final serum concentration was 20% in a final assay volume of 300 μl. After 30, 90, 120, and 150 min of incubation at 37°C, 10 μl of samples were serially diluted in GC broth with 0.05% saponin and cultured on GC agar. The number of colonies from triplicate wells was counted after overnight incubation and the data are expressed as the average log10 CFU ml−1.
PMN-killing assay. PMNs were elicited from wild-type BALB/c and BALB/c-Lpsd mice through peritoneal lavage and the capacity of PMNs to kill N. gonorrhoeae was measured using a modification of the tumbling tube assay as described previously.55 Serum (10%) from normal BALB/c mice (NMS) was used to opsonize the bacteria to control for differences in the killing activity of sera from these two mouse strains. Bacteria that were pre-incubated with HI-NMS, which we previously found does not opsonize gonococcal for PMN uptake,55, 56 were incubated with PMNs in parallel to provide a baseline for loss of bacterial viability during the assay. The number of viable gonococci recovered from each test condition was determined after 0, 45, and 90 min incubation by quantitative culture. The averages of triplicate cultures were calculated and results are expressed as the percentage survival (100 × (number of NMS-opsonized CFU recovered at 90 min divided by the number of HI-NMS-opsonized CFU)).
Flow cytometric analysis. Differentiated BMDMs from BALB/c and BALB/c-Lpsd mice were prepared as described above. After stimulation under different conditions for 24 h, cells were collected and stained with a phycoerythrin-conjugated anti-TLR2 antibody (eBioscience category # 12-9021-82) and a biotinylated antibody for the macrophage marker F4/80 (BioLegend, San Diego, CA; category #122603) plus streptovidin-phycoerythrin-Cy5 (BD Biosciences, San Jose, CA; category #554062). Cells were analyzed by flow cytometry using a FACScan microfluorimeter (Becton Dickinson, San Jose, CA). A total of 10,000 events were counted for each condition.
Statistical analysis. The average duration of recovery and colonization load over time were compared between groups by repeated-measures analysis of variance with Bonferroni's correction using SPSS software (IBM, New York, NY). The influx of PMNs in the infected group on any day was compared with its uninfected group by unpaired t-test. Levels of vaginal cytokines and chemokines as measured by multiplex assay were analyzed using a Mann–Whitney U-test with 95% confidence intervals. For the in vitro stimulation assays, each data point was assayed in triplicate, and graphed as mean±s.e., and compared using an unpaired t-test. GraphPad software was used for all other statistical tests (GraphPad, La Jolla, CA).
References
CDC ( U.S. Department of Health and Human Services, Atlanta, 2010 ).
Fleming, D.T. & Wasserheit, J.N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm. Infect. 75, 3–17 (1999).
Edwards, J.L. & Apicella, M.A. The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women. Clin. Microbiol. Rev. 17, 965–981, table of contents (2004).
Hook, E.W. & Handsfield, H.H. in Sexually Transmitted Diseases (Holmes, K.K. et al. eds) 451–466 ( McGraw-Hill Companies, New York, 1999 ).
Cates, W. Jr ., Rolfs, R.T. Jr . & Aral, S.O. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol. Rev. 12, 199–220 (1990).
Westrom, L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am. J. Obstet. Gynecol. 138, 880–892 (1980).
Jerse, A.E. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67, 5699–5708 (1999).
Palsson-McDermott, E.M. & O'Neill, L.A. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology. 113, 153–162 (2004).
Vogel, S.N. et al. Construction of a BALB/c congenic mouse, C.C3H-Lpsd, that expresses the Lpsd allele: analysis of chromosome 4 markers surrounding the Lps gene. Infect. Immun. 62, 4454–4459 (1994).
Packiam, M., Veit, S.J., Anderson, D.J., Ingalls, R.R. & Jerse, A.E. Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses. Infect. Immun. 78, 433–440 (2010).
Song, W. et al. Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice. Vaccine 26, 5741–5751 (2008).
Poltorak, A. et al. Genetic and physical mapping of the Lps locus: identification of the Toll-4 receptor as a candidate gene in the critical region. Blood Cells Molecules Dis. 24, 340–355 (1998).
Fisette, P.L., Ram, S., Andersen, J.M., Guo, W. & Ingalls, R.R. The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kB activation in epithelial cells in a TLR2-dependent manner. J. Biol. Chem. 278, 46252–46260 (2003).
Ingalls, R.R., Lien, E. & Golenbock, D.T. Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through Toll-like receptor 2. Infect. Immun. 69, 2230–2236 (2001).
Feinen, B., Jerse, A.E., Gaffen, S.L. & Russell, M.W. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection. Mucosal. Immunol. 3, 312–321 (2010).
Brandtzaeg, P., Joo, G.B., Brusletto, B. & Kierulf, P. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb. Res. 57, 271–278 (1990).
Brandtzaeg, P. et al. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159, 195–204 (1989).
Brandtzaeg, P., Mollnes, T.E. & Kierulf, P. Complement activation and endotoxin levels in systemic meningococcal disease. J. Infect. Dis. 160, 58–65 (1989).
Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P. & Espevik, T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169, 333–338 (1989).
Waage, A. et al. Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J. Exp. Med. 170, 1859–1867 (1989).
Fichorova, R.N., Cronin, A.O., Lien, E., Anderson, D.J. & Ingalls, R.R. Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of Toll-like receptor 4-mediated signaling. J. Immunol. 168, 2424–2432 (2002).
Massari, P. et al. Cutting edge: immune stimulation by neisserial porins is Toll-like receptor 2 and MyD88 dependent. J. Immunol. 168, 1533–1537 (2002).
Herbst-Kralovetz, M.M. et al. Quantification and comparison of Toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia. Am. J. Reprod. Immunol. 59, 212–224 (2008).
Pioli, P.A. et al. Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect. Immun. 72, 5799–5806 (2004).
Ohmori, Y. & Hamilton, T.A. IFN-gamma selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages. J. Immunol. 153, 2204–2212 (1994).
Tran, E.H., Prince, E.N. & Owens, T. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 164, 2759–2768 (2000).
Apicella, M.A. et al. Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J. Infect. Dis. 162, 506–512 (1990).
Farzadegan, H. & Roth, I.L. Scanning electron microscopy and freeze-etching of gonorrhoeal urethral exudate. Br. J. Vener. Dis. 51, 83–91 (1975).
Ovcinnikov, N.M. & Delektorskij, V.V. Electron microscope studies of gonococci in the urethral secretions of patients with gonorrhoea. Br. J. Vener. Dis. 47, 419–439 (1971).
Watt, P.J. The fate of gonococci in polymorphonuclear leucocytes. J. Med. Microbiol. 3, 501–509 (1970).
Gibbs, D.L. & Roberts, R.B. The interaction in vitro between human polymorphonuclear leukocytes and Neisseria gonorrhoeae cultivated in the chick embryo. J. Exp. Med. 141, 155–171 (1975).
Rest, R.F., Fischer, S.H., Ingham, Z.Z. & Jones, J.F. Interactions of Neisseria gonorrhoeae with human neutrophils: effects of serum and gonococcal opacity on phagocyte killing and chemiluminescence. Infect. Immun. 36, 737–744 (1982).
Thomas, D.W., Hill, J.C. & Tyeryar, F.J. Jr . Interaction of gonococci with phagocytic leukocytes from men and mice. Infect. Immun. 8, 98–104 (1973).
Casey, S.G., Shafer, W.M. & Spitznagel, J.K. Neisseria gonorrhoeae survive intraleukocytic oxygen-independent antimicrobial capacities of anaerobic and aerobic granulocytes in the presence of pyocin lethal for extracellular gonococci. Infect. Immun. 52, 384–389 (1986).
Simons, M.P., Nauseef, W.M. & Apicella, M.A. Interactions of Neisseria gonorrhoeae with adherent polymorphonuclear leukocytes. Infect. Immun. 73, 1971–1977 (2005).
Criss, A.K., Katz, B.Z. & Seifert, H.S. Resistance of Neisseria gonorrhoeae to non-oxidative killing by adherent human polymorphonuclear leucocytes. Cell Microbiol. 11, 1074–1087 (2009).
Montminy, S.W. et al. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat. Immunol. 7, 1066–1073 (2006).
Branger, J. et al. Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect. Immun. 72, 788–794 (2004).
Wang, X. et al. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J. Immunol. 168, 810–815 (2002).
Chapes, S.K., Mosier, D.A., Wright, A.D. & Hart, M.L. MHCII, Tlr4 and Nramp1 genes control host pulmonary resistance against the opportunistic bacterium Pasteurella pneumotropica. J. Leukoc. Biol. 69, 381–386 (2001).
Hart, M.L., Mosier, D.A. & Chapes, S.K. Toll-like receptor 4-positive macrophages protect mice from Pasteurella pneumotropica-induced pneumonia. Infect. Immun. 71, 663–670 (2003).
Bhan, U. et al. Cooperative interactions between TLR4 and TLR9 regulate interleukin 23 and 17 production in a murine model of gram negative bacterial pneumonia. PLoS One. 5, e9896 (2010).
Higgins, S.C., Jarnicki, A.G., Lavelle, E.C. & Mills, K.H. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177, 7980–7989 (2006).
Jordan, J.M., Woods, M.E., Olano, J. & Walker, D.H. The absence of Toll-like receptor 4 signaling in C3H/HeJ mice predisposes them to overwhelming rickettsial infection and decreased protective Th1 responses. Infect. Immun. 76, 3717–3724 (2008).
Cole, J.G., Fulcher, N.B. & Jerse, A.E. Opacity proteins increase Neisseria gonorrhoeae fitness in the female genital tract due to a factor under ovarian control. Infect. Immun. 78, 1629–1641 (2010).
Hirata, T. et al. Expression of Toll-like receptors 2, 3, 4, and 9 genes in the human endometrium during the menstrual cycle. J. Reprod. Immunol. 74, 53–60 (2007).
Yao, X.D., Fernandez, S., Kelly, M.M., Kaushic, C. & Rosenthal, K.L. Expression of Toll-like receptors in murine vaginal epithelium is affected by the estrous cycle and stromal cells. J. Reprod. Immunol. 75, 106–119 (2007).
Dalal, S.J., Estep, J.S., Valentin-Bon, I.E. & Jerse, A.E. Standardization of the Whitten effect to induce susceptibility to Neisseria gonorrhoeae in female mice. Contemp. Top. Lab. Anim. Sci. 40, 13–17 (2001).
Eades-Perner, A.M. et al. Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern. Cancer Res. 54, 4169–4176 (1994).
Edwards, J.L. et al. A co-operative interaction between Neisseria gonorrhoeae and complement receptor 3 mediates infection of primary cervical epithelial cells. Cell Microbiol. 4, 571–584 (2002).
Kallstrom, H., Liszewski, M.K., Atkinson, J.P. & Jonsson, A.B. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 25, 639–647 (1997).
Cohen, M.S. et al. Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development. J. Infect. Dis. 169, 532–537 (1994).
Vonck, R.A., Darville, T., O'Connell, C.M. & Jerse, A.E. Chlamydial infection increases gonococcal colonization in a novel murine coinfection model. Infect. Immun. 79, 1566–1577 (2011).
Cone, R.A. et al. Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect. Dis. 6, 90 (2006).
Wu, H. & Jerse, A.E. Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection. Infect. Immun. 74, 4094–4103 (2006).
Soler-Garcia, A.A. & Jerse, A.E. Neisseria gonorrhoeae catalase is not required for experimental genital tract infection despite the induction of a localized neutrophil response. Infect. Immun. 75, 2225–2233 (2007).
Acknowledgements
This work was supported by NIH/NIAID grants R01 AI42053 and U19 AI31496 (to AEJ), and R01 AI46613 and U19 AI084048 (to RRI).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declared no conflict of interest.
Rights and permissions
About this article
Cite this article
Packiam, M., Wu, H., Veit, S. et al. Protective role of Toll-like receptor 4 in experimental gonococcal infection of female mice. Mucosal Immunol 5, 19–29 (2012). https://doi.org/10.1038/mi.2011.38
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mi.2011.38